Notice Number: NOT-CA-17-072
Key Dates
Release Date: July 6, 2017
RFA-CA-17-027
Issued by
National Cancer Institute (NCI)
Purpose
The purpose of this Notice is to inform potential applicants about a change in application due date for RFA-CA-17-027 "Pediatric Early Phase Clinical Trials Network (UM1)" from August 16, 2017 to September 14 2017.
Other Key Dates for RFA-CA-17-027 are updated as shown below:
Open Date (Earliest Submission Date) |
August 14, 2017 |
Letter of Intent Due Date(s) |
30 days prior to the application due date |
Application Due Date(s) |
September 14, 2017, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
|
AIDS Application Due Date(s) |
Not Applicable
|
Scientific Merit Review |
October-November 2017 |
Advisory Council Review |
January 2018 |
Earliest Start Date |
April 2018 |
Expiration Date |
September 15, 2017 |
Inquiries
Please direct all inquiries to:
Malcolm A. Smith, MD, PhD
National Cancer Institute (NCI)
Telephone: 240-276-6087
Email: [email protected]
and Human Services (HHS)
